Clinical trial

To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol

NCT01272362

Study summary

ClinicalTrials.gov

To Determine the Relationship Between Baseline Reversibility and the Efficacy of Indacaterol

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE4

Loading study purpose, treatment groups and outcomes…

View the complete registry record, eligibility and contacts at ClinicalTrials.gov

Drugs and interventions used in this trial

1 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

DRUG · Unmapped registry intervention Indacaterol Find medicine records · Find other trials using this name

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2010-04-01

PhasePHASE4

Conditions

Chronic Obstructive Pulmonary Disease (COPD)verified · MONDO: chronic obstructive pulmonary disease

Interventions

IndacaterolDRUG

Sponsors & collaborators

Novartis Pharmaceuticalslead sponsor

Mapped research locations

ParisFrance5 ToulouseFrance2 StrasbourgFrance2 LilleFrance2 NantesFrance2 DijonFrance2 AmiensFrance2 MulhouseFrance2 Saint-QuentinFrance2 AlbiFrance2 ThionvilleFrance2 BastiaFrance2

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01272362 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.